Atomistry » Chlorine » PDB 6v52-6vck » 6v8n
Atomistry »
  Chlorine »
    PDB 6v52-6vck »
      6v8n »

Chlorine in PDB 6v8n: Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17

Enzymatic activity of Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17

All present enzymatic activity of Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17:
2.3.1.48;

Protein crystallography data

The structure of Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17, PDB code: 6v8n was solved by A.S.Gardberg, J.E.Wilson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 52.46 / 2.30
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 45.650, 104.820, 169.120, 90.00, 90.00, 90.00
R / Rfree (%) 20 / 24.7

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17 (pdb code 6v8n). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17, PDB code: 6v8n:

Chlorine binding site 1 out of 1 in 6v8n

Go back to Chlorine Binding Sites List in 6v8n
Chlorine binding site 1 out of 1 in the Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of the P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1703

b:38.7
occ:1.00
 O A:HOH1814 2.9 35.2 1.0
O A:HOH1819 3.2 39.4 1.0
N A:LEU1398 3.3 38.6 1.0
CE2 A:TYR1446 3.7 42.9 1.0
C14 A:QS11704 3.7 37.1 1.0
CA A:TYR1397 3.8 41.3 1.0
CG A:LEU1398 3.9 38.0 1.0
C A:TYR1397 4.0 37.1 1.0
O A:LEU1398 4.0 37.5 1.0
CD1 A:LEU1398 4.0 41.3 1.0
CD2 A:TYR1446 4.0 41.7 1.0
OH A:TYR1467 4.3 37.9 1.0
CA A:LEU1398 4.3 37.8 1.0
C15 A:QS11704 4.3 38.3 1.0
O A:CYS1438 4.3 44.2 1.0
O A:SER1396 4.5 38.8 1.0
C A:LEU1398 4.6 38.8 1.0
N A:TYR1397 4.6 42.0 1.0
CB A:LEU1398 4.6 38.7 1.0
O A:TRP1436 4.7 30.8 1.0
O A:HOH1812 4.8 30.1 1.0
C13 A:QS11704 4.8 37.4 1.0
CZ A:TYR1446 4.8 44.1 1.0
C A:SER1396 4.9 38.7 1.0
CB A:TYR1397 4.9 42.9 1.0
CD2 A:LEU1398 4.9 37.0 1.0
CD1 A:TYR1397 5.0 46.9 1.0

Reference:

J.E.Wilson, A.Huhn, A.S.Gardberg, F.Poy, F.Brucelle, V.Vivat, G.Patel, C.Patel, R.Cummings, R.Sims, J.Levell, J.E.Audia, A.Bommi-Reddy, N.Cantone. Early Drug Discovery Efforts Towards the Identification of EP300/Cbp Histone Acetyltransferase (Hat) Inhibitors. Chemmedchem 2020.
ISSN: ESSN 1860-7187
PubMed: 32181984
DOI: 10.1002/CMDC.202000007
Page generated: Sat Jul 12 20:48:28 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy